Introduction: new therapeutic approaches to bronchiolitis obliterans

G. Snell (Melbourne, Australia)

Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Session: Recent advances in graft dysfunction after lung transplantation
Session type: Oral Presentation
Number: 4506

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Snell (Melbourne, Australia). Introduction: new therapeutic approaches to bronchiolitis obliterans. Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19
Year: 2004

Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004



Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005



Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet?
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55
Year: 2004

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008



The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Treatment options in patients with bronchiolitis obliterans syndrome
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Post-transplant bronchiolitis obliterans
Source: Eur Respir J 2003 Dec 01;22(6):1007-1018
Year: 2003



Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004

Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Post-transplant bronchiolitis obliterans
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158
Year: 2003

Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004

Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure?
Source: Eur Respir J 2011; 37: 10-12
Year: 2011


A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Early diagnosis of chronic rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004

Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



Postinfection bronchiolitis obliterans in structure of chronic lung diseases in children
Source: Eur Respir J 2005; 26: Suppl. 49, 29s
Year: 2005

Fourth lung transplantation for bronchiolitis obliterans in a patient with cystic fibrosis
Source: Annual Congress 2007 - Complications and success in lung transplantation
Year: 2007


Azithromycin in bronchiolitis obliterans (BO) and BO organizing pneumonia complicating bone marrow transplantation
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008